The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells (Q33376263)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

The prognosis for patients with chronic myeloid leukemia who have clonal cytogenetic abnormalities in philadelphia chromosome-negative cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

Philadelphia chromosome

1 reference

object named as

Philadelphia chromosome

2 August 2024

based on heuristic

inferred from title

Carlo Gambacorti-Passerini

11

object named as

Carlo Gambacorti-Passerini

0 references

François Guilhot

object named as

François Guilhot

17

0 references

object named as

Brian J Druker

16

0 references

Andreas Hochhaus

object named as

Andreas Hochhaus

5

0 references

Hagop Kantarjian

9

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jorge Eduardo Cortes

2

object named as

Jorge Cortes

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Michele Baccarani

6

object named as

Michele Baccarani

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dietger Niederwieser

10

object named as

Dietger Niederwieser

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

object named as

Ron Paquette

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Michael W N Deininger

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Byung Park

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Richard Stone

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Thomas Fischer

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Charlene So

12

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Insa Gathmann

13

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

John M Goldman

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Douglas Smith

15

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

110

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1509-1519

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of 34 patients with clonal chromosomal abnormalities in Philadelphia-negative cells during imatinib treatment of Philadelphia-positive chronic myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosomal abnormalities in Ph- cells of patients on imatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Population-based study of cancer among carriers of a constitutional structural chromosomal rearrangement

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

The p38 mitogen-activated protein kinase pathway plays a critical role in thrombin-induced endothelial chemokine production and leukocyte recruitment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of myelosuppression during therapy with imatinib mesylate in patients with chronic myelogenous leukemia in chronic phase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal evolution in Philadelphia chromosome negative cells following successful treatment with Imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelodysplastic features developing in Philadephia-negative cells during imatinib mesylate therapy for CML: report of a new case

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon alpha

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of Y chromosome loss in hematologic disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of centrosome and chromosome aberrations by imatinib in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with Imatinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22936

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22936

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33376263&oldid=2218879544"